tert-Butyl 3-propoxypyrrolidine-1-carboxylate, 97.0%, 100mg

Methyl 2-methylbenzo[d]thiazole-5-carboxylate, 95.0%, 1g

Imidazo[1,2-a]pyridin-2-ylmethanamine hydrochloride, 97.0%, 1g

Plan PLPHi S40x/0.65 phase contrast IOS infinity corrected objective

2-({[(tert-Butoxy)carbonyl]amino}methyl)pyridine-4-carboxylic acid, 98%, 1g

5-(Aminomethyl)-6-methylpyridin-2-amine, 98%, 250mg

2-AMINO-3-(5-IODO-1H-INDOL-3-YL)PROPANOIC ACID, 95.0%, 250mg

4-(Trifluoromethyl)pyridine-2-carboxylic acid, 97.0%, 25g

ethyl 2-methyl-3-oxo-2,3-dihydro-1H-pyrazole-4-carboxylate, 95+%, 1g

Methyl 2-(propan-2-yloxy)pyridine-4-carboxylate, 95%, 500mg

4-Chloro-6-fluoroquinoline>98.0%(GC)1g

Ethyl 3,4-Dihydroxybenzoate>98.0%(GC)(T)25g

(R)-4-(Dibenzylamino)-3-fluoro-2-methylbutan-2-ol, 97%, 1g